These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 7911441)

  • 1. Somatostatin and somatostatin analogues: pharmacokinetics and pharmacodynamic effects.
    Harris AG
    Gut; 1994; 35(3 Suppl):S1-4. PubMed ID: 7911441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacodynamic effects of Sandostatin in the gastrointestinal tract.
    Gyr KE; Meier R
    Digestion; 1993; 54 Suppl 1():14-9. PubMed ID: 8103010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of the somatostatin analogue sandostatin (SMS 201-995) on gastrointestinal, pancreatic and biliary function and hormone release in normal men.
    Lembcke B; Creutzfeldt W; Schleser S; Ebert R; Shaw C; Koop I
    Digestion; 1987; 36(2):108-24. PubMed ID: 2883060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacodynamic effects of Sandostatin in the gastrointestinal tract.
    Gyr KE; Meier R
    Metabolism; 1992 Sep; 41(9 Suppl 2):17-21. PubMed ID: 1518430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical pharmacokinetics of octreotide. Therapeutic applications in patients with pituitary tumours.
    Chanson P; Timsit J; Harris AG
    Clin Pharmacokinet; 1993 Nov; 25(5):375-91. PubMed ID: 8287633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of pentagastrin-stimulated acid secretion after subcutaneous administration of a new somatostatin analogue.
    Whitehouse I; Beglinger C; Rüttimann G; Gyr K
    Gut; 1986 Feb; 27(2):141-6. PubMed ID: 2868973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Octreotide, a new somatostatin analogue.
    Katz MD; Erstad BL
    Clin Pharm; 1989 Apr; 8(4):255-73. PubMed ID: 2653711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Octreotide, analog of somatostatin. Pharmacological properties and therapeutic applications in pituitary endocrine tumors].
    Chanson P; Timsit J; Harris AG
    Presse Med; 1993 Dec; 22(40):2009-16. PubMed ID: 7907419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human pharmacological effects of SMS 201-995 on gastric secretion.
    Gyr KE; Whitehouse I; Beglinger C; Köhler E; Dettwiler S; Fried M
    Scand J Gastroenterol Suppl; 1986; 119():96-102. PubMed ID: 2876511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rat pancreas after long-term treatment with the somatostatin analogue octreotide.
    von Schönfeld J; Meisse F; Müller MK
    Exp Physiol; 1995 Nov; 80(6):1031-8. PubMed ID: 8962703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of somatostatin analogue octreotide on amylase secretion from mouse pancreatic acini.
    Ishiguro H; Hayakawa T; Kondo T; Shibata T; Kitagawa M; Sakai Y; Sobajima H; Nakae Y; Tanikawa M
    Digestion; 1993; 54(4):207-12. PubMed ID: 7694882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Somatostatin analogues and exocrine pancreatic secretion.
    Gullo L
    Digestion; 1996; 57 Suppl 1():93. PubMed ID: 8813482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Debut of a somatostatin analog: octreotide in review.
    Zindel LR
    Conn Med; 1989 Dec; 53(12):741-4. PubMed ID: 2558839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Octreotide. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in conditions associated with excessive peptide secretion.
    Battershill PE; Clissold SP
    Drugs; 1989 Nov; 38(5):658-702. PubMed ID: 2689136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Octreotide: a clinical update.
    Meier RF; Reichert MM
    Saudi J Gastroenterol; 1998 Sep; 4(3):147-55. PubMed ID: 19864763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of octreotide, a long-acting somatostatin analogue, on plasma amino acid uptake by the pancreas.
    Gullo L; Pezzilli R; Ancona D; Labate AM; Barbara L
    Pancreas; 1991 Nov; 6(6):668-72. PubMed ID: 1780327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of somatostatin analogue (SMS 201-995, Sandostatin) on pancreatic secretion in humans.
    Creutzfeldt W; Lembcke B; Fölsch UR; Schleser S; Koop I
    Am J Med; 1987 May; 82(5B):49-54. PubMed ID: 2884879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simultaneous observation of endocrine and exocrine functions of the pancreas responding to somatostatin in man.
    Emoto T; Miyata M; Izukura M; Yumiba T; Mizutani S; Sakamoto T; Matsuda H
    Regul Pept; 1997 Jan; 68(1):1-8. PubMed ID: 9094748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of octreotide in patients with cirrhosis and portal hypertension; relationship between the plasma levels of the analogue and the magnitude and duration of the reduction in corrected wedged hepatic venous pressure.
    Jenkins SA; Nott DM; Baxter JN
    HPB Surg; 1998; 11(1):13-21. PubMed ID: 9830576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of SMS 201-995, a somatostatin analogue, on the exocrine pancreatic secretion and gut hormone release in dogs.
    Misumi A; Shiratori K; Lee KY; Barkin JS; Chey WY
    Surgery; 1988 Apr; 103(4):450-5. PubMed ID: 2895501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.